In vivo hydroquinone exposure causes tracheal hyperresponsiveness due to TNF secretion by epithelial cells  by Shimada, Ana Lúcia Borges et al.
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Hydroquinone  (HQ)  is  the  main  oxidative  substance  in  cigarette  smoke  and  a toxic  product  of  ben-
zene  biotransformation.  Although  the respiratory  tract  is  an  inlet  pathway  of  HQ  exposure,  its effect
on  airway  muscle  responsiveness  has  not  been  assessed.  We  thus  investigated  the  effects  of low  dose
in  vivo  HQ-exposure  on  tracheal  responsiveness  to a muscarinic  receptor  agonist.  Male  Swiss  mice  were
exposed  to  aerosolised  5%  ethanol/saline  solution  (HQ  vehicle;  control)  or  0.04  ppm  HQ  (1 h/day  for  5
days)  and  tracheal  rings  were  collected  1  h  after  the last  exposure.  HQ  exposure  caused  tracheal  hyper-
responsiveness  to methacholine  (MCh),  which  was  abolished  by  mechanical  removal  of  the  epithelium.
This  hyperresponsiveness  was  not  dependent  on  neutrophil  inﬁltration,  but  on  tumour  necrosis  factor
(TNF)  secretion  by  epithelial  cells.  This  conclusion  was  based  on  the  following  data:  (1) trachea  from
HQ-exposed  mice  presented  a higher  amount  of  TNF,  which  was  abrogated  following  removal  of  the
epithelium;  (2)  the  trachea  hyperresponsiveness  and TNF  levels  were  attenuated  by  in  vivo  chlorpro-
mazine  (CPZ)  treatment,  an  inhibitor  of TNF  synthesis.  The  involvement  of  HQ-induced  TNF  secretion  in
trachea  mast  cell  degranulation  was  also  demonstrated  by the  partial  reversion  of  tracheal  hyperrespon-
siveness  in  sodium  cromoglicate-treated  animals,  and  the  in  vivo HQ-exposure-induced  degranulation
of  trachea  connective  tissue  and  mucosal  mast  cells,  which  was  reversed  by  CPZ treatment.  Our  data
show  that  in  vivo HQ exposure  indirectly  exacerbates  the  parasympathetic-induced  contraction  of  air-
way  smooth  muscle  cells,  mediated  by TNF  secreted  by  tracheal  epithelial  cells,  clearly  showing  the link
between  environmental  HQ  exposure  and  the  reactivity  of  airways.. Introduction
Hydroquinone (HQ) is the main oxidative compound found in
igarette smoke, and in this context has recently been associated
ith the increased incidence of age-related macular degeneration
n human smokers (Bertram et al., 2009; Pons and Marin-Castan˜o,
011). In addition, HQ is a metabolite of benzene, which is respon-
ible for hematotoxicity, immunosuppressive and carcinogenic
ffects (Kettle and Winterbourn, 1992; McGregor, 2007; Medinsky
t al., 1995; Snyder, 2002, 2004). Although the use of benzene
as been under regulatory control for the last 20 years, its toxi-
ity remains an environmental issue, especially in industrialised
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itária,  São Paulo, SP, CEP 05.508-900, Brazil. Tel.: +55 11 30911193;
 fax: +55 11 38156593.
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nations and in the burn of benzene-modiﬁed fuel (Nunes et al.,
2011; Yang, 2011). Therefore, both HQ and benzene have con-
tributed to environmental and occupational toxicity.
Exposure to pollutants leads to inﬂammation, oxidative stress
and immune-modulation in the airways and is associated with
the symptoms of asthma, including lung inﬂammation and bron-
choconstriction (Mendell and Heath, 2005). The trachea is one
of the ﬁrst functional and mechanical barriers to pollutants
(Shusterman, 2011; Turetz et al., 2009) and the induction and per-
sistence of tracheal reactivity is a hallmark of airway diseases such
as asthma, and an undesirable symptom in terms of resolution of
the inﬂammatory process (Cockcroft and Davis, 2006; Myers and
Tomasio, 2011; Reuter et al., 2008).
The trachea is a complex tissue composed of chondrocytes,
Open access under the Elsevier OA license.respiratory epithelial cells, mast cells, smooth muscle cells and col-
lagen matrix, and is highly irrigated by blood vessels and innervated
by C-ﬁbres, parasympathetic, sympathetic and non-adrenergic-
non-cholinergic nerves (Ten Hallers et al., 2004). These components
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apidly respond to irritant compounds in the air, a response that
s vital to protect the host. In this context, they release stored
nd/or synthesised products, which induce smooth cell contrac-
ion to prevent the entrance of harmful substances (Cockcroft,
010; Lino-dos-Santos-Franco et al., 2010; Säfholm et al., 2011;
ownley and Horiba, 2003). The group of endogenous mediators
ecreted by stimulated trachea cells, including acetylcholine, his-
amine, cytokines, leukotrienes and prostaglandins, interacts with
eceptors present in smooth muscle cells to induce intracellular
athways involved in contraction (Cockcroft, 2010; Cockcroft and
avis, 2006; Lino-dos-Santos-Franco et al., 2010). Tumour necro-
is factor (TNF) is a cytokine that is produced by several cell
ypes found in the airways, including epithelial and mast cells,
n response to a wide range of agents. TNF induces smooth mus-
le cell contractility in the airway and regulates the phenotype of
hese smooth muscle cells, predisposing for hyperresponsiveness
Adner et al., 2002; Amrani et al., 2000; Thomas, 2001; Thomas
t al., 1995). The effects of TNF are mediated by its interactions
ith two related receptors, TFNR1 (TNFR1a; CD120a; p55) and
NFR2 (TNFR1b; CD120b; p75), which are expressed in upper
irway and lung tissues, by alveolar macrophages, monocytes, lym-
hocytes and granulocytes present in the bronchoalveolar lavage,
mall blood vessels and sensory neurons (Cardell et al., 2008; Van
ouwelingen et al., 2002; Thomas, 2001).
Our group has recently demonstrated HQ-induced lung toxicity,
ith mice exposed to low doses of HQ showing reduced leuko-
yte migration into LPS-inﬂamed lung due to the modiﬁcation
n neutrophil membrane receptors and impaired monocyte-
hemoattractant protein secretion by mononuclear cells (Ribeiro
t al., 2011; Shimada et al., in press). The effects of in vivo HQ expo-
ure on the contraction of airway smooth cells were experimentally
valuated in the present study. The data obtained reinforce the rel-
vance of environmental pollutants and airway diseases as a public
ealth issue.
. Material and methods
.1.  Chemicals
Hydroquinone 99%, lipopolysaccharide from Escherichia coli 026:B6, metha-
holine,  chlorpromazine and sodium cromoglicate were purchased from
igma–Aldrich  (St Louis, MO,  USA); the TNF ELISA kit was purchased from
D  Pharmingen (San Diego, CA, USA); DMEM and gentamicin were obtained from
ibco (Carlsbad, CA, USA); all RT-PCR reagents were purchased from Promega
orporation  (Madison, WI,  USA); rabbit polyclonal anti-TNF receptor-1 and
abbit  polyclonal anti-TNF receptor-2 antibodies were purchased from Abcam
Cambridge,  MA,  USA).
.2.  Animals
Eighteen-week-old male Swiss mice were supplied by the Animal House of the
chool of Pharmaceutical Sciences and Chemistry Institute of the University of Sao
aulo. The animals were fed a standard pellet diet and water ad libitum, and before
ach experimental procedure they were anaesthetised with ketamine/xylazine solu-
ion (80:8 mg/kg; i.p.). All procedures were performed according to the Brazilian
ociety  of Science of Laboratory Animals (SBCAL) and approved by the local ethics
ommittee (Protocol number 196).
.3. In vivo HQ exposure
Using an ultrasonic nebuliser (NS® , Sao Paulo, Brazil) animals were exposed
o  hydroquinone (HQ) solution at 25 ppm (1.5 mg/60 ml)  for 1 h a day for 5 days,
ccording  to Ribeiro et al. (2011) and Shimada et al. (in press). After 1 h, the
Q  concentration in the chamber was 0.04 ppm, measured according to NIOSH,
rotocol  no. 5004 (Ribeiro et al., 2011). Control animals were exposed to HQ
ehicle  (5% ethanol in saline). This protocol of HQ exposure is known to induce
ung  toxicity, as demonstrated by impaired leukocyte migration during inﬂam-
ation. Furthermore, it represents a low exposure condition, as the HQ time
eighted average (TWA) is 0.4 ppm (Ribeiro et al., 2011; Shimada et al., in
ress). Letters 211 (2012) 10– 17 11
2.4.  Ex vivo tracheal responsiveness to methacholine (MCh)
Tracheal rings were mounted for isometric force quantiﬁcation by means of
two  steel hooks in a 15 ml  organ bath according to De Lima and Da Silva (1998).
Force  contraction was recorded using a force displacement transducer and a chart
recorder (Powerlab® , Labchart, AD Instruments). Brieﬂy, tracheal rings were sus-
pended in an organ bath ﬁlled with Krebs–Henseleit (KH) buffer composed of (mM):
NaCl 115.0; KCl 4.6; CaCl2·2H2O 2.5; KH2PO4 1.2; MgSO4·7H2O 2.5; NaHCO3 25
and  glucose 11.0 at 37 ◦C. Tracheal rings were maintained in continuously aer-
ated  conditions (95% O2 and 5% CO2). Following the equilibrium period (30 min),
the  tracheal tissue was adjusted to 0.5 g. Tissue viabilities were assessed by
replacing  KH solution in the bath with KCl buffer (60 mM)  and comparing the
contraction  force produced with those obtained in KH conditions. Tracheal respon-
siveness to MCh  was  measured by constructing cumulative dose-response curves
(10−9 to 3 × 10−4 M).
2.5.  Mechanical removal of tracheal epithelium
The epithelium was removed by gently rubbing the tracheal lumen with a
polyethylene  tube (5–6 times), according to the technique described by González
and  Santacana (2000). Only viable epithelial-denuded tracheal segments, as
assessed by KCl buffer, were utilised in the experiments. In order to verify
the  effective removal of the epithelial layer, tracheal segments were stained
with  haematoxylin and eosin (HE) and histology was  evaluated by light optical
microscopy.
2.6.  Inﬁltration of inﬂammatory cells in tracheal tissue following HQ exposure
In  order to investigate the inﬁltration of inﬂammatory cells into tracheal tissue
following  in vivo HQ exposure, HE staining was  performed on intact trachea and
histology was evaluated by light optical microscopy.
2.7. Nitrite and TNF quantiﬁcation in tracheal explants
Nitrite and TNF levels were determined in samples of supernatants of tracheal
explants  in culture according to Lino-dos-Santos-Franco et al. (2010). Nitrite (NO2−)
is a stable NO metabolite and can be used to measure NO production (Feelisch, 1993).
NO2− concentrations were quantiﬁed using the Griess reaction and the results were
expressed in M. The concentrations of TNF were measured using enzyme-linked
immunosorbent assay (ELISA) kits according to the manufacturer’s instructions. The
results were expressed as pg/g of tissue.
Brieﬂy, the tracheal tissues of HQ and vehicle groups were removed and main-
tained  in Dulbecco-modiﬁed Eagle’s medium (DMEM) supplemented with NaHCO3
(7 mM)  and gentamicin (45 g/ml), penicillin (100 U/ml), streptomycin (100 g/ml)
and amphotericin B (1.5 g/ml). The ex vivo trachea culture was incubated at 37 ◦C,
5% CO2, for 24 h according to Lino-dos-Santos-Franco et al. (2010).
TNF  levels were also determined in epithelium-denuded trachea culture super-
natant.
2.8.  Pharmacological treatments
To  investigate the involvement of TNF on HQ-exposed trachea MCh-
hyperresponsiveness, chlorpromazine (CPZ; 4 mg/kg) or vehicle (PBS) was
administered  i.p. 1 h before each vehicle/HQ exposure according to Mengozzi et al.
(1994). In sequence, the rings were collected and submitted to the concentration-
response  curves to MCh  were calculated as indicated above.
To  investigate the role of mast cells in HQ-exposed trachea, animals were
exposed  to sodium cromoglicate by aerosol for 5 consecutive days (SC; 2.5 mg/ml,
15 min) or vehicle (distilled water) according to Lino-dos-Santos-Franco et al.
(2006). The animals were then exposed to vehicle or HQ and the concentration-
response  curves to MCh  of the tracheal rings were calculated as indicated above.
2.9. Evaluation of mast cell degranulation
Following  vehicle or HQ exposure tracheal tissues were removed and ﬁxed in
2% paraformaldehyde and 2% glutaraldehyde in 0.1 M sodium phosphate buffer (pH
7.4) for 24 h at 4 ◦C. They were then fragmented, washed, dehydrated in ethanol,
cleared  in xylene and embedded in HistosecTM (Merck, Whitehouse Station, NJ,
USA). Sections were cut (3 m; HYRAX M60, Zeiss, GR), mounted on slides, and
stained  with 0.25% toluidine blue and 0.25% borate sodium solution. The number
of  intact and degranulated mast cells in tracheal tissue was recorded under a high-
power objective (40×). The area of analysis was measured using Axiovision software
(Zeiss,  GR). Mast cell degranulation was determined according to the presence of
toluidine-labelled extravasated granules in the extracellular matrix, as described
by  Damazo et al. (2001). Data were expressed as cells/mm2 (analysing at least ten
distinct sections per trachea).2.10.  Tracheal mRNA expression
Tracheal  TNFR1 and TNFR2 mRNA expression was quantiﬁed by polymerase
chain  reaction following reverse transcription. Brieﬂy, total RNA was extracted from
1 cology Letters 211 (2012) 10– 17
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Fig. 1. In vivo HQ exposure causes tracheal hyperresponsiveness to methacholine
(MCh).  The animals were exposed to vehicle or HQ (0.04 ppm; 1 h/day; 5 days).
Following  1 h, the tracheal rings were removed and maintained in an organ bath in
F
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he trachea using Trizol reagent, according to the manufacturer’s instructions. RNA
as quantiﬁed by absorbance at OD 260. cDNA was  synthesised from the total RNA
2 g) using an oligo(dT)15 primer (20 g/ml) following incubation (70 ◦C, 5 min) in
he presence of a deoxynucleotide triphosphate mixture (dNTP, 2 mM),  ribonuclease
nhibitor  (20 U), and Moloney murine leukaemia virus reverse transcriptase (200 U)
hat had been dissolved in a reverse transcriptase buffer (25 l ﬁnal volume). The
everse transcription reaction occurred during incubation at 42 ◦C for 60 min. The
DNA obtained was incubated with Taq DNA Polymerase (2.5 U), 3′- and 5′-speciﬁc
rimers  (0.4 M),  and a dNTP mix  (200 M)  in a thermophilic DNA polymerase
uffer  that contained MgCl2 (1.5 mM).  The primer sequences used were described
y  Cardell et al. (2008):
TNFR1: Forward primer CGATAAAGCCACACCCACAAC
Reverse  primer GAGACCTTTGCCCACTTTTCAC
TNFR2: Forward primer GAGACACTGCAGAGCCATGAGA
Reverse  primer CAGGCCACTTTGACTGCAATC
.11. Tracheal TNFR1 and TNFR2 protein expression
Tracheal TNFR1 and TNFR2 protein expression was quantiﬁed by Western
lot.  Brieﬂy, tracheal tissue proteins were extracted in Tris buffer (50 mM,  pH
.4)  containing leupeptin (10 g/ml), soybean trypsin inhibitor (10 g/ml), apro-
inin (2 g/ml) and PMSF (1 mM).  Homogenate proteins (87.5 g) were separated
y  sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS–PAGE; 12%)
ccording to Laemmli (1970) and were electrophoretically transferred to a nitrocel-
ulose membrane. After blocking nonspeciﬁc sites with 5% non-fat milk, membranes
ere  incubated overnight with the primary rabbit polyclonal antibody raised against
NF receptor-1 or rabbit polyclonal anti-TNF receptor-2 (500 ng/ml). Membranes
ere  washed with Tris-buffered saline containing 0.1% Tween-20 and incubated
ith  horseradish peroxidase-conjugated goat anti-rabbit secondary antibody. A
hemiluminescent assay (HRP SuperSignalWestPico; Pierce, USA) was  used to detect
mmunoreactive bands. The intensities of the bands were estimated by densitometry
nalysis  and were compared to the intensity of -actin expression.
.12.  Statistical analysisThe  mean and standard error of the mean (SEM) were analysed using the Stu-
ent’s  tailed paired or unpaired t test or ANOVA followed by Tukey’s test. GraphPad
rism  5.0 software (San Diego, CA, USA) was used and P < 0.05 was considered sig-
iﬁcant.
ig. 2. Role of epithelium in in vivo HQ-induced tracheal hyperresponsiveness. The anima
racheal  rings with intact or denuded epithelium were maintained in an organ bath in ord
f  ten animals. (B) Morphological analysis of tracheal tissue with haematoxylin–eosin dye
ndicates the complete absence of the epithelium following the removal procedure (n = 3order to record the contractile responses to MCh. Data are expressed as mean ± s.e.m.
of ten animals. *P < 0.05 vs. vehicle.
3. Results
3.1. In vivo HQ exposure causes tracheal hyperresponsiveness
dependent on epithelium
Intact  tracheal segments obtained from HQ-exposed animals
showed hyperresponsiveness to MCh  (Fig. 1). However, following
mechanical removal of the epithelium, responsiveness returned
to control levels (Fig. 2A). According to histological analysis, rub-
bing the lumen of the tracheal rings was  effective at removing the
epithelium (Fig. 2B).
ls were exposed to vehicle or HQ (0.04 ppm; 1 h/day; 5 days). (A) Following 1 h, the
er to record the contractile responses to MCh. Data are expressed as mean ± s.e.m.
 (20×) showing tracheal rings with intact (1) or denuded epithelium (2). The arrow
). *P < 0.05 vs. HQ + epithelium.
A.L.B. Shimada et al. / Toxicology Letters 211 (2012) 10– 17 13
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Hig. 3. Histological analysis of tracheal tissue demonstrating the absence of inﬂ
aematoxylin-eosin and analysed by light optical microscopy (40×).
.2. HQ-induced tracheal hyperresponsiveness is not dependent
n  neutrophil inﬁltration
It  has previously been established that inﬁltrating neutrophils
ncrease the responsiveness of tracheal muscle to parasympathetic
timulation (Bethel et al., 1992). Data presented in Fig. 3 show that
Q exposure for 5 days did not induce neutrophil inﬂux into the
racheal tissue, suggesting that the HQ-induced tracheal hyperre-
ponsiveness to MCh  was not dependent on inﬁltrated neutrophils.
.3. HQ-induced tracheal hyperresponsiveness is not dependent
n  impaired NO production
As  NO produced by constitutive nitric oxide synthases pre-
ents MCh-induced smooth muscle contraction (Meurs et al.,
000), we investigated whether HQ exposure could impair gas
roduction. Equivalent levels of NO2− were detected in the
Q (6.3 ± 0.4 M/mg  tissue) and vehicle (5.6 ± 0.5 M/mg  tissue)
reatment groups, indicating that inhibition of NO production is not
 mechanism involved in the HQ-induced tracheal hyperrespon-
iveness in response to MCh.
.4. HQ-induced tracheal hyperresponsiveness is dependent on
NF  secretion by epithelial cells
Based on relevance of the epithelium in tracheal hyperrespon-
iveness and the contractile effect of TNF on the upper airway
ystem (Adner et al., 2002; Thomas, 2001; Thomas et al., 1995;
uretz et al., 2009), the production of this cytokine in response
o HQ exposure was investigated. In vivo HQ exposure increased
he TNF concentration in the supernatant of intact tracheal tissue
ulture, which in turn was markedly reduced by removal of the
pithelium (Fig. 4A). Although the mRNA levels of TNFR2, but not
NFR1, in the tracheal tissue were enhanced after in vivo HQ expo-
ure (Fig. 4B and C), the protein expression of both receptors was
ot modiﬁed by HQ exposure (Fig. 4D and E).
To corroborate the role of TNF in HQ-induced tracheal hyper-
esponsiveness to MCh, animals were pre-treated with CPZ, an
nhibitor of TNF synthesis, and exposed to HQ. The effectiveness of
he pharmacological treatment was demonstrated by the marked
eduction of TNF in the trachea supernatant culture (Fig. 5A). The
articipation of TNF in HQ-induced tracheal hyperresponsiveness
o MCh  was further conﬁrmed as CPZ pre-treatment abrogated the
Q-induced tracheal reactivity (Fig. 5B).atory inﬁltration. Vehicle- (A) and HQ- (B) exposed trachea were stained with
3.5.  Association between TNF secretion and mast cell
degranulation in HQ-induced tracheal hyperresponsiveness to
MCh
It  has been show that TNF is able to induce mast cell degranula-
tion, leading to the release of a wide range of mediators, including
pre-formed TNF (Brzezin´ska-Blaszczyk et al., 2000; Brzezin´ska-
Blaszczyk and Pietrzak, 1997; Kim et al., 2007; Reuter et al., 2008).
In this study we demonstrated that in vivo HQ exposure induces
mucosal and connective mast cell degranulation, which was par-
tially reversed with CPZ treatment (Fig. 6), indicating that the
tracheal contraction induced by TNF is dependent, at least in part,
on products secreted by mast cells.
In fact, the role of mast cells in HQ-induced hyperresponsiveness
to MCh  was demonstrated in trachea collected from animals treated
with SC, a stabiliser of mast cell membranes, prior to HQ exposure.
The results obtained showed that the pharmacological treatment
partially reversed the tracheal hyperresponsiveness to MCh  (Fig. 7).
3.6. Discussion
To  our knowledge, this is the ﬁrst demonstration that in vivo
HQ exposure enhances tracheal responsiveness to a cholinergic
agent. Such hyperresponsiveness is not dependent on the direct
HQ actions on smooth muscle cells, but is mediated by TNF, the
secretion of which by tracheal epithelial cells is up-regulated by HQ
exposure. This mechanism may  be related to the higher incidence
of airway diseases in smokers and susceptible individuals and may
contribute to the changes in lung morphology and physiology that
are observed in chronic smokers, as HQ is the most important pro-
oxidant agent in tobacco smoke (Bertram et al., 2009; Bhalla et al.,
2009; Pons and Marin-Castan˜o, 2011; van der Vaart et al., 2004).
MCh  is a non-selective muscarinic agonist that is widely
employed as a pharmacological tool in experimental and clinical
studies to measure alterations in muscle cell contractility and tra-
cheobronchial secretions (Cockcroft and Davis, 2006; Cockcroft,
2010; De Oliveira et al., 2011). By acting on M3 coupled G-
protein receptors (GPCR) present in bronchial smooth muscle,
MCh enhances the contraction of airway smooth muscle via Ca2+-
dependent and Ca2+-independent pathways. The activation of
phospholipase C and CD38 pathways enhances free cytosolic Ca2+,
which promotes the calmodulin-dependent activation of myosin
light chain kinase (MLCK). In addition, activated Rho kinases inhibit
myosin light chain phosphatase (MLCP), enhancing iCa2+ sensi-
tivity. Both intracellular pathways induce the coupling of myosin
14 A.L.B.  Shimada et al. / Toxicology Letters 211 (2012) 10– 17
Fig. 4. TNF secretion, TNF receptor mRNA and protein expression. (A) The concentration (pg/ml) of TNF was assayed by ELISA. The concentration of TNF was measured in
the  supernatants of tracheal segments with intact or denuded epithelium after exposure to HQ or vehicle. (B) TNFR1 and TNFR2 mRNA expression evaluated by RT-PCR was
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lot  and compared to -actin expression. (E) Representative image of nitrocellulos
re  expressed as mean ± s.e.m. of three to ﬁve animals in each group.*P < 0.05 vs. ve
ight chain (MLC) and cell contraction (Amrani and Panettieri,
998; Murthy, 2006). Our data show that in vivo HQ exposure
avours these pathways, leading to enhanced tracheal contraction
n response to MCh. Moreover, we clearly show that this is not a
irect effect of HQ, but is dependent on HQ-induced TNF secre-
ion by epithelial cells. This evidence was obtained by removing
pithelial cells from tracheas, after which the MCh-induced tra-
heal reactivity of HQ-exposed animals was equivalent to that
bserved in trachea obtained from control animals.
ig. 5. Involvement of TNF in in vivo HQ exposure-induced tracheal hyperresponsiveness
.p.).  Following 1 h, they were exposed to vehicle or HQ (0.04 ppm; 1 h/day; 5 days) and t
f TNF levels by ELISA. (B) The contractile response to MCh  was measured in trachea p
ean ± s.e.m. of ﬁve animals. *P < 0.05 vs. PBS + HQ; #P < 0.05 and **P < 0.001 vs. vehicle – electrophoresis. (D) TNFR1 and TNFR2 protein expression was  assayed by Western
brane showing bands of approximately 55 kDa (TNFR1) and 75 kDa (TNFR2). Data
#P < 0.05 and **P < 0.01 vs. vehicle + epithelium; ##P < 0.01 vs. HQ + epithelium.
The literature suggests that an increase in airway respon-
siveness is closely associated with acute airway inﬂammation,
depending on the presence of inﬂammatory cells, not only
eosinophils, but also neutrophils in the airway system (Cockcroft
and Davis, 2006; Nakagome and Nagata, 2011). Controversially,
our ﬁndings show that this may  not be the mechanism underly-
ing HQ-induced upper airway hyperresponsiveness, as neutrophil
inﬁltration and/or morphological changes were not found in the
tracheal tissue after HQ exposure. Corroborating this data, our
. (A) Animals were pre-treated with vehicle (PBS) or chlorpromazine (CPZ; 4 mg/kg,
he tracheal rings were removed and maintained in culture to allow quantiﬁcation
re-treated with CPZ or PBS and exposed to vehicle or HQ. Data are expressed as
CPZ; ##P < 0.01 vs. vehicle + CPZ.
A.L.B. Shimada et al. / Toxicology Letters 211 (2012) 10– 17 15
Fig. 6. Mast cell degranulation in tracheal tissue. The animals were pre-treated with CPZ and exposed to vehicle or HQ (0.04 ppm; 1 h/day; 5 days). (A) Morphological analysis
of  trachea stained with toluidine blue. Arrows indicate connective tissue mast cells (CTMC) and arrowheads indicate mucosal mast cells (MMC)  present in vehicle (1); HQ-
(2)  or CPZ + HQ- (3) exposed tracheas. (B) Number of degranulated mast cells in tracheal tissue. Data show the number of CTMC and MMC  per mm2 and are the mean ± s.e.m.
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Sf  ﬁve animals. The presence of intact, degranulated mast cells and the relative per
roup has recently demonstrated that HQ exposure per se did not
nduce the migration of inﬂammatory cells into the lung tissue. On
he contrary, it impairs the LPS-induced inﬁltration of polymor-
honuclear and mononuclear cells into the lungs (Ribeiro et al.,
011; Shimada et al., in press).
It has been proposed that HQ in vitro causes smooth muscle cell
ontraction in the guinea-pig trachea, rabbit aorta and rat/mouse
nococcygeus muscle (Güc et al., 1988; Hobbs et al., 1991; Ilhan and
ahin, 1986) by acting as a NO scavenger (Hobbs et al., 1991). The
articipation of NO was ruled out in the present study, since HQ
xposure did not modify the secretion of NO2− by tracheal tissue.
ig. 7. Involvement of mast cells in in vivo HQ exposure-induced tracheal hyperre-
ponsiveness.  Animals were pre-treated with distilled water or sodium cromoglicate
SC;  2.5 mg/ml; 15 min; 5 days). Following 1 h, they were exposed to vehicle or HQ
0.04 ppm; 1 h/day; 5 days) and the tracheal rings were removed and maintained in
n organ bath in order to record the contractile responses to MCh. Data are expressed
s  the mean ± s.e.m. of ﬁve animals. *P < 0.05 vs. distilled water + HQ; #P < 0.05 vs.
C + HQ.es are shown. *P < 0.05 vs. vehicle and #P < 0.05 vs. HQ.
In fact, as mentioned earlier, our ﬁndings demonstrate that
HQ-induced tracheal hyperresponsiveness was  strongly related
to TNF secretion by tracheal epithelial cells. The role of TNF in
cholinergic-induced smooth muscle cell contraction, as observed
in this study, has been demonstrated previously (Adner et al., 2002;
Thomas, 2001; Thomas et al., 1995), but the mechanisms of actions
remain unclear. It has been proposed that TNF, by acting on TNFR1,
enhances the GPCR agonist-evoked iCa2+ concentration, and con-
sequently enhances the phosphorylation of MLC  (Chen et al., 2003;
Parris et al., 1999), as well as causing the dysfunction of pre-
synaptic muscarinic (M2) receptors, which enhances the release
of acetylcholine (Nie et al., 2009). Chronic exposure to TNF has
also been associated with the desensitisation of G-protein coupled
receptors (Guo et al., 2005; Kang et al., 2006; Osawa et al., 2007). The
latter two  mechanisms have been implicated in asthma pathogene-
sis. It is noteworthy that other mechanisms may  also be involved, as
the elevated secretion of TNF causes airway smooth cell contraction
by activating different intracellular pathways, depending on pre-
and post-transcriptional activity (Tirumurugaan et al., 2007; Jude
et al., 2011). In addition, we herein show that the TNF action is not
dependent on the enhanced protein expression of TNFR1 or TNFR2,
which suggests that the elevated concentration of this cytokine in
response to in vivo HQ exposure may  alter the ability of TNFRs
to activate muscarinic receptors, the sensitivity or expression of
muscarinic receptors, or subsequent signalling pathways.
Mast  cell degranulation is a hallmark of airway hyperrespon-
siveness. Existing data on the mechanism by which TNF promotes
mast cell degranulation and consequently, the release of a wide
range of smooth muscle cell active mediators, including histamine,
cytokines and leukotrienes, is controversial (Brzezin´ska-Blaszczyk
et al., 2000, 2007; Brzezin´ska-Blaszczyk and Pietrzak, 1997). Here
we show that in vivo HQ exposure causes CTMC and MMC  degran-
ulation that is dependent on TNF release, as the pharmacological
inhibition of TNF synthesis reduced mast cell degranulation. Fur-
thermore, TNF-induced mast cell degranulation of the HQ-induced
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racheal hyperresponsiveness to MCh  was further highlighted
y the fact that pre-treatment with mast cell stabilizer partially
eversed tracheal hyperresponsiveness.
The data shown herein strongly suggest that the release of TNF
y tracheal epithelium after low levels of HQ exposure triggers
irway hyperresponsiveness in response to cholinergic stimula-
ion. In addition, secreted TNF plays an important role in mast cell
egranulation, with the subsequent release of chemical mediators
hat contribute to the maintenance of HQ-induced tracheal hyper-
esponsiveness. Together, the activation of these pathways may
ontribute to the development of airway diseases in subjects chron-
cally exposed to HQ, such as smokers and inhabitants of polluted
reas.
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